{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:22:47Z","timestamp":1791868967159,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Alport syndrome is an inherited disease characterized by progressive renal failure, hearing loss, and ocular abnormalities. Inheritance is X-linked (85%) or autosomal recessive (15%). Many renal physicians think of Alport syndrome as primarily affecting men. However, twice as many women are affected by the X-linked diseases. Affected women are commonly undiagnosed, but 15%\u201330% develop renal failure by 60 years and often hearing loss by middle age. Half of their sons and daughters are also affected. Autosomal recessive Alport syndrome is less common, but is often mistaken for X-linked disease. Recessive inheritance is suspected where women develop early-onset renal failure or lenticonus. Their family may be consanguineous. The prognosis for other family members is very different from X-linked disease. Other generations, including parents and offspring, are not affected, and on average only one in four of their siblings inherit the disease. All women with Alport syndrome should have their diagnosis confirmed with genetic testing, even if their renal function is normal, because of their own risk of renal failure and the risk to their offspring. Their mutations indicate the mode of inheritance and the likelihood of disease transmission to their children, and the mutation type suggests the renal prognosis for both X-linked and recessive disease. Women with X-linked Alport syndrome should be tested at least annually for albuminuria and hypertension. The \u201cExpert guidelines for the diagnosis and management of Alport syndrome\u201d recommend treating those with albuminuria with renin-angiotensin-aldosterone system (RAAS) blockade (and adequate birth control because of the teratogenic risks of angiotensin converting enzyme inhibitors), believing that this will delay renal failure. Current recommendations are that women with autosomal recessive Alport syndrome should be treated with RAAS blockade from the time of diagnosis. In addition, women should be offered genetic counseling, informed of their reproductive options, and monitored closely during pregnancy for the development of hypertension.<\/jats:p>","DOI":"10.2215\/cjn.00580116","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T00:34:47Z","timestamp":1465605287000},"page":"1713-1720","source":"Crossref","is-referenced-by-count":135,"title":["Alport Syndrome in Women and Girls"],"prefix":"10.2215","volume":"11","author":[{"given":"Judy","family":"Savige","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb","family":"Colville","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Rheault","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Gear","sequence":"additional","affiliation":[{"name":"Alport UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lennon","sequence":"additional","affiliation":[{"name":"Department of Paediatric Nephrology, Central Manchester University Hospitals National Health Service Foundation Trust, Manchester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lagas","sequence":"additional","affiliation":[{"name":"Alport Syndrome Foundation, Phoenix, Arizona;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Finlay","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville, Victoria, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Flinter","sequence":"additional","affiliation":[{"name":"Department of Genetics, Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport\u2019s syndrome. A report of 58 cases and a review of the literature","volume":"70","author":"Gubler","year":"1981","journal-title":"Am J Med"},{"key":"B2-20230813","first-page":"S20","article-title":"Alport\u2019s syndrome: experience at H\u00f4pital Necker","volume":"11","author":"Habib","year":"1982","journal-title":"Kidney Int Suppl"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic heterogeneity of Alport syndrome","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome","volume":"8","author":"Mochizuki","year":"1994","journal-title":"Nat Genet"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ejhg.2014.254","article-title":"Clinical utility gene card for: Alport syndrome - update 2014","volume":"23","author":"Hertz","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bjo.2009.158089","article-title":"Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum","volume":"93","author":"Fawzi","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ki.1992.402","article-title":"Alport syndrome and diffuse leiomyomatosis: deletions in the 5\u2032 end of the COL4A5 collagen gene","volume":"42","author":"Antignac","year":"1992","journal-title":"Kidney Int"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/humu.20091","article-title":"Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders","volume":"24","author":"Persikov","year":"2004","journal-title":"Hum Mutat"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/ajkd.2001.29217","article-title":"A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport\u2019s syndrome","volume":"38","author":"Dagher","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-011-1836-7","article-title":"Women and Alport syndrome","volume":"27","author":"Rheault","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ndt\/gfm024","article-title":"Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females","volume":"22","author":"Kashtan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","article-title":"Women with Alport syndrome: risks and rewards of kidney donation","volume":"24","author":"Kashtan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00467-007-0622-z","article-title":"Familial hematuria","volume":"24","author":"Kashtan","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","article-title":"Genetics of classic Alport\u2019s syndrome","volume":"2","author":"Flinter","year":"1988","journal-title":"Lancet"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"436046","DOI":"10.5402\/2012\/436046","article-title":"Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients","volume":"2012","author":"Gross","year":"2012","journal-title":"ISRN Pediatr"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.10581014","article-title":"Ocular features in Alport syndrome: pathogenesis and clinical significance","volume":"10","author":"Savige","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3129\/can j ophthalmol.i07-020","article-title":"Giant macular hole in Alport syndrome","volume":"42","author":"Rahman","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamaophthalmol.2013.1452","article-title":"Temporal macular thinning associated with X-linked Alport syndrome","volume":"131","author":"Ahmed","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1093\/ndt\/gfq271","article-title":"Aortic abnormalities in males with Alport syndrome","volume":"25","author":"Kashtan","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","article-title":"Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling","volume":"17","author":"Gross","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-013-2682-6","article-title":"A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations","volume":"29","author":"Mohammad","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J Med Genet"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13816819709057125","article-title":"Ocular manifestations of autosomal recessive Alport syndrome","volume":"18","author":"Colville","year":"1997","journal-title":"Ophthalmic Genet"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1681\/ASN.2013080912","article-title":"Improving mutation screening in familial hematuric nephropathies through next generation sequencing","volume":"25","author":"Morini\u00e8re","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jpeds.2015.05.045","article-title":"Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report","volume":"167","author":"Nadeem","year":"2015","journal-title":"J Pediatr"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MNH.0000000000000119","article-title":"Pregnancy in advanced chronic kidney disease and end-stage renal disease","volume":"24","author":"Alkhunaizi","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.39314.439491.AD","article-title":"Use and misuse of preimplantation genetic testing","volume":"335","author":"Braude","year":"2007","journal-title":"BMJ"},{"key":"B36-20230813","first-page":"267","article-title":"Renal prognosis in women with hereditary nephritis","volume":"23","author":"Gr\u00fcnfeld","year":"1985","journal-title":"Clin Nephrol"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ki.1987.174","article-title":"Reduction of proteinuria by angiotensin converting enzyme inhibition","volume":"32","author":"Heeg","year":"1987","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201609000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:34Z","timestamp":1786369594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201609000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00580116","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726416373.793527146","asserted-by":"object"}]},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]}}}